{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:49Z","timestamp":1789706269570,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The absence of highly specific markers for malignant mesothelioma (MM) has served an obstacle for its diagnosis and development of molecular-targeting therapy against MM. Here, we show that a novel mucin-like membrane protein, sialylated protein HEG homolog 1 (HEG1), is a highly specific marker for MM. A monoclonal antibody against sialylated HEG1, SKM9-2, can detect even sarcomatoid and desmoplastic MM. The specificity and sensitivity of SKM9-2 to MM reached 99% and 92%, respectively; this antibody did not react with normal tissues. This accurate discrimination by SKM9-2 was due to the recognition of a sialylated <jats:italic>O<\/jats:italic>-linked glycan with HEG1 peptide. We also found that gene silencing of HEG1 significantly suppressed the survival and proliferation of mesothelioma cells; this result suggests that HEG1 may be a worthwhile target for function-inhibition drugs. Taken together, our results indicate that sialylated HEG1 may be useful as a diagnostic and therapeutic target for MM.<\/jats:p>","DOI":"10.1038\/srep45768","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T14:34:05Z","timestamp":1490970845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma"],"prefix":"10.1038","volume":"7","author":[{"given":"Shoutaro","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Washimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taihei","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyo","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yokose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Morohoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Tsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Yusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Togayachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Narimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzoh","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"BFsrep45768_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone, M. et al. Malignant mesothelioma: facts, myths, and hypotheses. J. Cell. Physiol. 227, 44\u201358 (2012).","journal-title":"J. Cell. Physiol."},{"key":"BFsrep45768_CR2","unstructured":"The Ministry of Health, Labour and Welfare in Japan. Trends in the number of deaths from mesothelioma by prefecture (21 major cities regrouped), based on Vital Statistics of Japan (Final data, 1995-2014). Sep. 3, 2015."},{"key":"BFsrep45768_CR3","unstructured":"World Health Organization. World Health Assembly Resolution 58.22 Elimination of Asbestos-Related Disease. WHO, Geneva, Switzerland (2006)."},{"key":"BFsrep45768_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/resp.12517","volume":"20","author":"SL Leong","year":"2015","unstructured":"Leong, S. L., Zainudin, R., Kazan-Allen, L. & Robinson, B. W. Asbestos in Asia. Respirology 20, 548\u2013555 (2015).","journal-title":"Respirology"},{"key":"BFsrep45768_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.sandf.2012.11.003","volume":"52","author":"M Kazama","year":"2012","unstructured":"Kazama, M. & Noda, T. Damage statistics (Summary of 2011 off the Pacific Coast of Tohoku Earthquake damage). Soils Found. 52, 780\u2013792 (2012).","journal-title":"Soils Found."},{"key":"BFsrep45768_CR6","doi-asserted-by":"publisher","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","volume":"10","author":"E Taioli","year":"2015","unstructured":"Taioli, E. et al. Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients. PLoS One 10, e0145039 (2015).","journal-title":"PLoS One"},{"key":"BFsrep45768_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1200\/JCO.1989.7.8.1157","volume":"7","author":"P Ruffie","year":"1989","unstructured":"Ruffie, P. et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J. Clin. Oncol. 7, 1157\u20131168 (1989).","journal-title":"J. Clin. Oncol."},{"key":"BFsrep45768_CR8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5858\/2008-132-397-AOITTD","volume":"132","author":"AM Marchevsky","year":"2008","unstructured":"Marchevsky, A. M. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch. Pathol. Lab. Med. 132, 397\u2013401 (2008).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFsrep45768_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","volume":"27","author":"NG Ord\u00f3\u00f1ez","year":"2003","unstructured":"Ord\u00f3\u00f1ez, N. G. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am. J. Surg. Pathol. 27, 1031\u20131051 (2003).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFsrep45768_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/PAS.0b013e31814faacf","volume":"32","author":"DM Padgett","year":"2008","unstructured":"Padgett, D. M., Cathro, H. P., Wick, M. R. & Mills, S. E. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin. Am. J. Surg. Pathol. 32, 123\u2013127 (2008).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFsrep45768_CR11","doi-asserted-by":"publisher","first-page":"e39889","DOI":"10.1371\/journal.pone.0039889","volume":"7","author":"K Washimi","year":"2012","unstructured":"Washimi, K. et al. Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells. PLoS One 7, e39889 (2012).","journal-title":"PLoS One"},{"key":"BFsrep45768_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth, M. A. & Swanson, B. J. Mucins in cancer: protection and control of the cell surface. Nature Rev. Cancer 4, 45\u201360 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFsrep45768_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. Nature Rev. Cancer 15, 540\u2013555 (2015).","journal-title":"Nature Rev. Cancer"},{"key":"BFsrep45768_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/bcr2577","volume":"12","author":"A Cazet","year":"2010","unstructured":"Cazet, A., Julien, S., Bobowski, M., Burchell, J. & Delannoy, P. Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res. 12, 204 (2010).","journal-title":"Breast Cancer Res."},{"key":"BFsrep45768_CR15","first-page":"220","volume":"3","author":"Y Inagaki","year":"2009","unstructured":"Inagaki, Y. et al. Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers. Biosci. Trends 3, 220\u2013232 (2009).","journal-title":"Biosci. Trends"},{"key":"BFsrep45768_CR16","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.1038\/srep05924","volume":"4","author":"Y Kato","year":"2014","unstructured":"Kato, Y. & Kaneko, M. K. A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin. Sci. Rep. 4, 5924 (2014).","journal-title":"Sci. Rep."},{"key":"BFsrep45768_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.immuni.2016.05.014","volume":"44","author":"AD Posey Jr.","year":"2016","unstructured":"Posey, A. D. Jr. et al. Engineered CAR T Cells targeting the cancer-associated Tn-glycoform of the membrane mucin MUC1 control adenocarcinoma. Immunity 44, 1444\u20131454 (2016).","journal-title":"Immunity"},{"key":"BFsrep45768_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/onc.2012.158","volume":"32","author":"DW Kufe","year":"2013","unstructured":"Kufe, D. W. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 32, 1073\u20131081 (2013).","journal-title":"Oncogene"},{"key":"BFsrep45768_CR19","first-page":"d95","volume":"5","author":"KL Carraway","year":"2000","unstructured":"Carraway, K. L. et al. Multiple facets of sialomucin complex\/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update). Front. Biosci. 5, d95\u2013107 (2000).","journal-title":"Front. Biosci."},{"key":"BFsrep45768_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/0008-5472.CAN-08-0587","volume":"69","author":"SC Chauhan","year":"2009","unstructured":"Chauhan, S. C. et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res. 69, 765\u2013774 (2009).","journal-title":"Cancer Res."},{"key":"BFsrep45768_CR21","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ejca.2011.07.004","volume":"48","author":"S Reinartz","year":"2012","unstructured":"Reinartz, S., Failer, S., Schuell, T. & Wagner, U. CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. Eur. J. Cancer 48, 1558\u20131569 (2012).","journal-title":"Eur. J. Cancer"},{"key":"BFsrep45768_CR22","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cub.2003.11.055","volume":"13","author":"JD Mably","year":"2003","unstructured":"Mably, J. D., Mohideen, M. A., Burns, C. G., Chen, J. N. & Fishman, M. C. heart of glass regulates the concentric growth of the heart in zebrafish. Curr. Biol. 13, 2138\u20132147 (2003).","journal-title":"Curr. Biol."},{"key":"BFsrep45768_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nm.1918","volume":"15","author":"B Kleaveland","year":"2009","unstructured":"Kleaveland, B. et al. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nature Med. 15, 169\u2013176 (2009).","journal-title":"Nature Med."},{"key":"BFsrep45768_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/modpathol.3800032","volume":"17","author":"C Langner","year":"2004","unstructured":"Langner, C., Ratschek, M., Rehak, P., Schips, L. & Zigeuner, R. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod. Pathol. 17, 180\u2013188 (2004).","journal-title":"Mod. Pathol."},{"key":"BFsrep45768_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/modpathol.3800445","volume":"18","author":"EA Rakha","year":"2005","unstructured":"Rakha, E. A. et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod. Pathol. 18, 1295\u20131304 (2005).","journal-title":"Mod. Pathol."},{"key":"BFsrep45768_CR26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.5858\/133.5.814","volume":"133","author":"HB Armah","year":"2009","unstructured":"Armah, H. B. & Parwani, A. V. Epithelioid sarcoma. Arch. Pathol. Lab. Med. 133, 814\u2013819 (2009).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFsrep45768_CR27","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.humpath.2012.01.005","volume":"43","author":"MM Streppel","year":"2012","unstructured":"Streppel, M. M. et al. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Hum. Pathol. 43, 1755\u20131763 (2012).","journal-title":"Hum. Pathol."},{"key":"BFsrep45768_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nmeth803","volume":"2","author":"A Kuno","year":"2005","unstructured":"Kuno, A. et al. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nature Methods 2, 851\u2013856 (2005).","journal-title":"Nature Methods"},{"key":"BFsrep45768_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/glycob\/cwp197","volume":"20","author":"K Fukushima","year":"2010","unstructured":"Fukushima, K., Satoh, T., Baba, S. & Yamashita, K. \u03b11,2-Fucosylated and \u03b2-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer. Glycobiology 20, 452\u2013460 (2010).","journal-title":"Glycobiology"},{"key":"BFsrep45768_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/glycob\/cwq170","volume":"21","author":"E Machado","year":"2011","unstructured":"Machado, E. et al. N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. Glycobiology 21, 376\u2013386 (2011).","journal-title":"Glycobiology"},{"key":"BFsrep45768_CR31","doi-asserted-by":"publisher","first-page":"18275","DOI":"10.1074\/jbc.M111.280297","volume":"287","author":"I Breloy","year":"2012","unstructured":"Breloy, I. et al. O-linked N,N\u2019-diacetyllactosamine (LacdiNAc)-modified glycans in extracellular matrix glycoproteins are specifically phosphorylated at subterminal N-acetylglucosamine. J. Biol. Chem. 287, 18275\u201318286 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFsrep45768_CR32","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/infdis\/jiu239","volume":"210","author":"Y Rossez","year":"2014","unstructured":"Rossez, Y. et al. The lacdiNAc-specific adhesin LabA mediates adhesion of Helicobacter pylori to human gastric mucosa. J. Infect. Dis. 210, 1286\u20131295 (2014).","journal-title":"J. Infect. Dis."},{"key":"BFsrep45768_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1158\/1541-7786.MCR-10-0443","volume":"9","author":"DM Maher","year":"2011","unstructured":"Maher, D. M., Gupta, B. K., Nagata, S., Jaggi, M. & Chauhan, S. C. Mucin 13: structure, function, and potential roles in cancer pathogenesis. Mol. Cancer Res. 9, 531\u2013537 (2011).","journal-title":"Mol. Cancer Res."},{"key":"BFsrep45768_CR34","first-page":"874","volume":"9","author":"DW Kufe","year":"2009","unstructured":"Kufe, D. W. Mucins in cancer: function, prognosis and therapy. Nature Rev . Cancer 9, 874\u2013885 (2009).","journal-title":"Cancer"},{"key":"BFsrep45768_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/modpathol.3800027","volume":"17","author":"K Llinares","year":"2004","unstructured":"Llinares, K. et al. Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma. Mod. Pathol. 17, 150\u2013157 (2004).","journal-title":"Mod. Pathol."},{"key":"BFsrep45768_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1083\/jcb.200208145","volume":"161","author":"S Schenk","year":"2003","unstructured":"Schenk, S. et al. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J. Cell Biol. 161, 197\u2013209 (2003).","journal-title":"J. Cell Biol."},{"key":"BFsrep45768_CR37","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00018-008-7440-8","volume":"65","author":"MJ Wieduwilt","year":"2008","unstructured":"Wieduwilt, M. J. & Moasser, M. M. The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell. Mol. Life Sci. 65, 1566\u20131584 (2008).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFsrep45768_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1083\/jcb.201205109","volume":"199","author":"AR Gingras","year":"2012","unstructured":"Gingras, A. R., Liu, J. J. & Ginsberg, M. H. Structural basis of the junctional anchorage of the cerebral cavernous malformations complex. J. Cell Biol. 199, 39\u201348 (2012).","journal-title":"J. Cell Biol."},{"key":"BFsrep45768_CR39","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1074\/mcp.M500108-MCP200","volume":"4","author":"CY Jia","year":"2005","unstructured":"Jia, C. Y., Nie, J., Wu, C., Li, C. & Li, S. S. Novel Src homology 3 domain-binding motifs identified from proteomic screen of a Pro-rich region. Mol. Cell. Proteomics 4, 1155\u20131166 (2005).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFsrep45768_CR40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrc1649","volume":"5","author":"MM Fuster","year":"2005","unstructured":"Fuster, M. M. & Esko, J. D. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526\u2013542 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep45768_CR41","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.2174\/13816128112092472","volume":"18","author":"MP Torres","year":"2012","unstructured":"Torres, M. P., Chakraborty, S., Souchek, J. & Batra, S. K. Mucin-based targeted pancreatic cancer therapy. Curr. Pharm. Des. 18, 2472\u20132481 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"BFsrep45768_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","volume":"97","author":"N Usami","year":"2006","unstructured":"Usami, N. et al. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci. 97, 387\u2013394 (2006).","journal-title":"Cancer Sci."},{"key":"BFsrep45768_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.bjc.6605786","volume":"103","author":"S Tsuji","year":"2010","unstructured":"Tsuji, S. et al. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. Br. J. Cancer 103, 517\u2013523 (2010).","journal-title":"Br. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep45768.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep45768","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/srep45768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/srep45768.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:49:09Z","timestamp":1671821349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep45768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,2]]}},"alternative-id":["BFsrep45768"],"URL":"https:\/\/doi.org\/10.1038\/srep45768","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]},"assertion":[{"value":"28 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.T., K.W., T.K., M.Yamashita, R.M., M.Yoshihara, and K.I. are listed as co-inventors on a patent application covering this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45768"}}